Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

15.5K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
15.5K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

82.3K
Overview
82.3K
Special Features of Adaptive Immunity01:20

Special Features of Adaptive Immunity

2.6K
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
2.6K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

14.2K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
14.2K
Hybridoma Technology01:31

Hybridoma Technology

16.7K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
16.7K
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

8.1K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
8.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Soluble Antigen Arrays Alter the Response of Epitope-Specific Diabetogenic T Cells.

ACS applied bio materials·2026
Same author

Soluble Antigen Array Displaying Proinsulin(F25D) Selectively Targets Anti-insulin B Cells without Hormonal Effects.

Molecular pharmaceutics·2026
Same author

Engineered Nonhormonal, Cationic Proinsulin Variants Prolong Lymphatic Drainage.

Molecular pharmaceutics·2025
Same author

Implementation of a Dementia-Specific Advance Care Planning Tool at a Program for All-Inclusive Care for the Elderly (PACE): A Quality Improvement Pilot Project.

Journal of gerontological nursing·2025
Same author

Impact of Hydrophobic, Hydrophilic, and Mucus-Binding Motifs on the Therapeutic Potential of Ceftazidime Analogs for Pulmonary Administration.

Antibiotics (Basel, Switzerland)·2025
Same author

Glatiramer Acetate Complexes CpG Oligodeoxynucleotides into Nanoparticles and Boosts Their TLR9-Driven Immunity.

Molecular pharmaceutics·2024

Related Experiment Video

Updated: Dec 9, 2025

Interrogating Individual Autoreactive Germinal Centers by Photoactivation in a Mixed Chimeric Model of Autoimmunity
11:12

Interrogating Individual Autoreactive Germinal Centers by Photoactivation in a Mixed Chimeric Model of Autoimmunity

Published on: April 11, 2019

7.4K

Autoantigen Tetramer Silences Autoreactive B Cell Populations.

Matthew A Christopher1, Stephanie N Johnson1, J Daniel Griffin1,2

  • 1Department of Pharmaceutical Chemistry, University of Kansas, 2095 Constant Avenue, Lawrence, Kansas 66047, United States.

Molecular Pharmaceutics
|September 9, 2020
PubMed
Summary

A novel multivalent antigen array, 4-arm PLP139-151, effectively silenced autoreactive B cells in a multiple sclerosis mouse model. This targeted approach ameliorated paralysis and reduced inflammatory cytokines, offering a promising new autoimmune therapy.

Keywords:
B cell receptorEAEantigen specificityautoimmunitymultivalenttolerance

More Related Videos

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model
11:31

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model

Published on: August 16, 2019

8.3K
Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
10:10

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Published on: November 8, 2016

9.0K

Related Experiment Videos

Last Updated: Dec 9, 2025

Interrogating Individual Autoreactive Germinal Centers by Photoactivation in a Mixed Chimeric Model of Autoimmunity
11:12

Interrogating Individual Autoreactive Germinal Centers by Photoactivation in a Mixed Chimeric Model of Autoimmunity

Published on: April 11, 2019

7.4K
High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model
11:31

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model

Published on: August 16, 2019

8.3K
Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
10:10

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Published on: November 8, 2016

9.0K

Area of Science:

  • Immunology
  • Neuroimmunology
  • Biochemistry

Background:

  • Current autoimmune therapies often involve broad immune suppression, lacking antigen specificity.
  • Pathogenic B cells recognize specific autoantigens via B cell receptors (BCR).
  • Multivalent antigen arrays offer a strategy to disarm autoreactive B cells through high-avidity BCR engagement.

Purpose of the Study:

  • To investigate the therapeutic potential of a multivalent antigen array targeting proteolipid protein (PLP139-151).
  • To evaluate the efficacy of 4-arm PLP139-151 in a mouse model of multiple sclerosis (experimental autoimmune encephalomyelitis).
  • To assess the mechanism of B cell disarmament and downstream effects on inflammation.

Main Methods:

  • Synthesis of a tetramer display of PLP139-151 (4-arm PLP139-151) using copper-catalyzed azide-alkyne cycloaddition.
  • Administration of 4-arm PLP139-151 to mice with experimental autoimmune encephalomyelitis.
  • Analysis of competitive binding, B cell depletion, and cytokine levels.

Main Results:

  • Subcutaneous administration of 4-arm PLP139-151 completely resolved paralysis in the mouse model.
  • The multivalent array demonstrated enhanced avidity for PLP139-151-specific IgG compared to the free peptide.
  • Treatment led to depletion of autoreactive B cells and a significant reduction in proinflammatory cytokines.

Conclusions:

  • 4-arm PLP139-151 effectively silences autoreactive B cell populations.
  • This targeted approach holds promise for treating autoimmune diseases like multiple sclerosis.
  • The findings support BCR engagement and high-avidity binding as a mechanism for autoimmune therapy.